Search Results for: drugmaker

Dr. Swati Piramal, VC, Piramal Life Sciences poses for the photographers during the press conference to announce Piramal Healthcare’s acquisition with Decision Resources Group in Mumbai on Wednesday, 16 May 2012.

Ajay Piramal, Chairman, Piramal Enterprises Ltd & Dr. Swati Piramal, VC, Piramal Life Sciences poses for the photographers during the press conference to announce Piramal Healthcare’s acquisition with Decision Resources Group in Mumbai on Wednesday, 16 May 2012.

Ajay Piramal, Chairman, Piramal Enterprises Ltd gestures during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd addressing the media during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd addressing the media during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd addressing the media during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd addressing while Dr. Swati Piramal, VC, Piramal Life Sciences looks on during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd addressing the media during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.

Ajay Piramal, Chairman, Piramal Enterprises Ltd, & Dr. Swati Piramal, VC, Piramal Life Sciences poses for the photographers during the press conference for an important announcement by Piramal Healthcare in Mumbai on Monday, 16 April 2012. Piramal healthcare has entered into an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG.